|
1
|
Jayadev R and Sherwood DR: Basement
membranes. Curr Biol. 27:R207–R211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
LeBleu VS, Macdonald B and Kalluri R:
Structure and function of basement membranes. Exp Biol Med
(Maywood). 232:1121–1129. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang J and Chaudhuri O: Beyond proteases:
Basement membrane mechanics and cancer invasion. J Cell Biol.
218:2456–2469. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yurchenco PD: Basement membranes: cell
scaffoldings and signaling platforms. Cold Spring Harb Perspect
Biol. 3:a0049112011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alečković M, Wei Y, LeRoy G, Sidoli S, Liu
DD, Garcia BA and Kang Y: Identification of Nidogen 1 as a lung
metastasis protein through secretome analysis. Genes Dev.
31:1439–1455. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martino-Echarri E, Fernández-Rodríguez R,
Rodríguez-Baena FJ, Barrientos-Durán A, Torres-Collado AX,
Plaza-Calonge Mdel C, Amador-Cubero S, Cortés J, Reynolds LE,
Hodivala-Dilke KM and Rodríguez-Manzaneque JC: Contribution of
ADAMTS1 as a tumor suppressor gene in human breast carcinoma.
Linking its tumor inhibitory properties to its proteolytic activity
on nidogen-1 and nidogen-2. Int J Cancer. 133:2315–2324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferraro DA, Patella F, Zanivan S, Donato
C, Aceto N, Giannotta M, Dejana E, Diepenbruck M, Christofori G and
Buess M: Endothelial cell-derived nidogen-1 inhibits migration of
SK-BR-3 breast cancer cells. BMC Cancer. 19:3122019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Watson KL, Jones RA, Bruce A and Moorehead
RA: The miR-200b/200a/429 cluster prevents metastasis and induces
dormancy in a murine claudin-low mammary tumor cell line. Exp Cell
Res. 369:17–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jones R, Watson K, Bruce A, Nersesian S,
Kitz J and Moorehead R: Re-expression of miR-200c suppresses
proliferation, colony formation and in vivo tumor growth of murine
claudin-low mammary tumor cells. Oncotarget. 8:23727–23749. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Campbell CI and Moorehead RA: Mammary
tumors that become independent of the type I insulin-like growth
factor receptor express elevated levels of platelet-derived growth
factor receptors. BMC Cancer. 11:4802011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Campbell CI, Thompson DE, Siwicky MD and
Moorehead RA: Murine mammary tumor cells with a claudin-low
genotype. Cancer Cell Int. 11:282011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chorner PM and Moorehead RA: A-674563, a
putative AKT1 inhibitor that also suppresses CDK2 activity,
inhibits human NSCLC cell growth more effectively than the pan-AKT
inhibitor, MK-2206. PLoS One. 13:e01933442018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dedhar S, Jewell K, Rojiani M and Gray V:
The receptor for the basement membrane glycoprotein entactin is the
integrin alpha 3/beta 1. J Biol Chem. 267:18908–18914.
1992.PubMed/NCBI
|
|
15
|
Dong LJ, Hsieh JC and Chung AE: Two
distinct cell attachment sites in entactin are revealed by amino
acid substitutions and deletion of the RGD sequence in the
cysteine-rich epidermal growth factor repeat 2. J Biol Chem.
270:15838–15843. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yi XY, Wayner EA, Kim Y and Fish AJ:
Adhesion of cultured human kidney mesangial cells to native
entactin: Role of integrin receptors. Cell Adhes Commun. 5:237–248.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rokavec M, Bouznad N and Hermeking H:
Paracrine induction of epithelial-mesenchymal transition between
colorectal cancer cells and its suppression by a
p53/miR-192/215/NID1 axis. Cell Mol Gastroenterol Hepatol.
7:783–802. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y, Zhu Y, Fan X, Zhang C, Wang Y,
Zhang L, Zhang H, Wen T, Zhang K, Huo X, et al: NID1, a new
regulator of EMT required for metastasis and chemoresistance of
ovarian cancer cells. Oncotarget. 8:33110–33121. 2017. View Article : Google Scholar : PubMed/NCBI
|
